Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Isoniazid Release from Suppositories Compounded with Selected Bases

Author(s):  Hudson Kristofer C, Asbill C Scott, Webster Andrew A

Issue:  Sep/Oct 2007 - Veterinary Compounding
View All Articles in Issue

Page(s):  433-437

Isoniazid Release from Suppositories Compounded with Selected Bases Page 1
Isoniazid Release from Suppositories Compounded with Selected Bases Page 2
Isoniazid Release from Suppositories Compounded with Selected Bases Page 3
Isoniazid Release from Suppositories Compounded with Selected Bases Page 4
Isoniazid Release from Suppositories Compounded with Selected Bases Page 5

Download in electronic PDF format for $75

Abstract:  There is an increasing need for an alternative route of isoniazid administration for prophylaxis and treatment of tuberculosis in children. The purpose of this study is to evaluate the in vitro release of isoniazid from extemporaneously compounded isoniazid suppositories with a goal of optimizing the suppository dosage form for this indication. Suppositories were compounded using three different base formulations (cocoa butter, Witepsol H15 Base F, and a combination of polyethylene glycols 3350, 1000, and 400). The release profiles of six compounded suppositories with isoniazid (100 mg) were tested with a United States Pharmacopeial Convention–approved dissolution apparatus. Isoniazid concentrations at predetermined time points were determined using high-performance liquid chromatographic analysis. The results show that drug release from the water-soluble base (mixed polyethylene glycols) was significantly greater than that from the lipophilic bases (cocoa butter and Witepsol H15). The percentage of isoniazid release from the polyethylene glycol suppository formulation (70 ± 1.4 mg/mL) was greater than that from the cocoa butter (55 ± 1.1 mg/mL) and Witepsol H15 Base F (18 ± 0.36 mg/mL) suppository formulations.

Related Keywords: isoniazid, tuberculosis, rectal suppositories, intrarectal administration, prevention, children, cocoa butter, Witepsol H15 Base F, polyethylene glycol, formulations, excipients

Related Categories: EXCIPIENTS, FORMULATIONS, PEER-REVIEWED, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C
, Asbill C Scott, Webster Andrew A
Sep/Oct 2007
Pg. 433-437

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309

Compounded Suppositories and Pharmaceutical Care
Duncan-Hewitt Wendy
, Rains John
Mar/Apr 1997
Pg. 93-99

Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits
Zia Hossein
, Rashed Suzette F, Quadir Mohammed, Needham Thomas E, Squillante Emilio
Sep/Oct 1998
Pg. 390-393

Compounding Pearls -- Wound Care: Base Selection
Riepl Mike
Mar/Apr 2020
Pg. 98-102

Progesterone Vaginal Suppositories (Polyethylene Glycol Bases)
Allen Loyd V Jr
Jan/Feb 1998
Pg. 66

Basics: Hollow-type Suppositories
Allen Loyd V Jr
Jul/Aug 2022
Pg. 302-307

Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
Jan/Feb 2022
Pg. 34-38

Enhanced Release of Diazepam from Hollow-Type Suppositories
Kaewnopparat N
, Kaewnopparat S, Rojanarat W, Ingkatawornwong S
Jul/Aug 2004
Pg. 310-312

A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Walker Heather
, Sridhar Vishak, Alexander Kenneth S
Nov/Dec 2011
Pg. 510-514

Isoniazid 300-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 232

Rifampin 300-mg and Isoniazid 150-mg Capsules
Allen Loyd V Jr
Jul/Aug 2013
Pg. 334

Isoniazid 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2020
Pg. 58

Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 501-508

Isoniazid 10-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 376

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane
Tenjarla Srini N
, Ward Earl S, Fox Janet L
Jan/Feb 1998
Pg. 83-88

Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories
Anderson Derick
, Amiji Mansoor M
May/Jun 2001
Pg. 234-237

Topical Oil-in-Water Cream Bases, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2002
Pg. 303-304

Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
Jul/Aug 2000
Pg. 289-293

Return to Top